Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 8131 AL 8145

Therapeutic Potential for Cannabidiol on Alzheimer's Disease-Related Neuroinflammation: A Systematic Review and Meta-Analysis

Wu S, Rajiah T, Ali AB.

Int J Mol Sci. 2025 Dec 11;26(24):11963. doi: 10.3390/ijms262411963.

Equivalence of Plasma and Serum for Clinical Measurement of p-tau217: Comparative Analyses of Four Blood-Based Assays

Chen Y, Albert AL, Sehrawat A, Farinas MF, L Lopez O, Zeng X, Cohen AD, Karikari TK.

J Neurochem. 2025 Jul;169(7):e70114. doi: 10.1111/jnc.70114.

New Research on Biomarkers in Alzheimer's Continuum

Vecchio I, Colica C.

Rev Recent Clin Trials. 2025;20(3):211-231. doi: 10.2174/0115748871331138250114052615.

Alzheimer's disease: assessing the therapeutic potential of anti-Aβ (Beta-Amyloid) treatments

Almutairi JA.

Cell Mol Biol (Noisy-le-grand). 2025 Feb 2;71(1):111-117. doi: 10.14715/cmb/2025.70.1.12.

Unlocking ocular biomarkers for early detection of Alzheimer's disease

Dave N, Lee M, Pavlou H, Im O, Goh K, Ulin S, Malzbender K, Shobin E, Sukumar A.

Alzheimers Dement. 2025 Feb;21(2):e14567. doi: 10.1002/alz.14567. Epub 2025 Feb 19.

Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China

Leng L, Liao Z, Lu P, Sun Y, Weng Q, Fan W, Zhu H, Wu W, Liu P, Liu X, Zhang K, Wang W, Luo B, Wang Z, Peng G.

J Alzheimers Dis. 2026 Feb;109(3):1346-1356. doi: 10.1177/13872877251406619. Epub 2025 Dec 15.

Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer's Disease and Frontotemporal Dementia

Petracci I, Bellini S, Goljanek-Whysall K, Quinlan LR, Fiszer A, Cakmak A, Njume CM, Borroni B, Ghidoni R.

Int J Mol Sci. 2025 Apr 5;26(7):3399. doi: 10.3390/ijms26073399.

Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer's disease

Shaw S, Porel P, Aran KR.

Mol Biol Rep. 2025 Apr 8;52(1):370. doi: 10.1007/s11033-025-10485-4.

Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease

López-Martos D, Suárez-Calvet M, Milà-Alomà M, Gispert JD, Salvadó G, Brugulat-Serrat A, Shekari M, Minguillon C, Zetterberg H, Blennow K, Grau-Rivera O, Sánchez-Benavides G; ALFA study.

Neurology. 2025 Nov 11;105(9):e214308. doi: 10.1212/WNL.0000000000214308. Epub 2025 Oct 17.

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study

Wang S, Xi J, Zhang M, Wang J.

Int J Biol Macromol. 2025 Mar;294:139394. doi: 10.1016/j.ijbiomac.2024.139394. Epub 2025 Jan 3.

Advances in Diagnostic Approaches for Alzheimer's Disease: From Biomarkers to Deep Learning Technology

Asif M, Ullah H, Jamil N, Riaz M, Zain M, Pushparaj PN, Rasool M.

CNS Neurol Disord Drug Targets. 2025;24(12):872-881. doi: 10.2174/0118715273374284250519053646.

The Biomarker Profile of Alzheimer's Disease for Disease-Modifying Treatment Eligibility: Questions and Debates

Athanasaki A, Tsantzali I, Theodorou A, Michalopoulou A, Constantinides VC, Boufidou F, Tzartos JS, Tsalouchidou PE, Zompola C, Paraskevas SG, Bonakis A, Giannopoulos S, Tsivgoulis G, Kapaki E, Paraskevas GP.

Int J Mol Sci. 2025 Sep 29;26(19):9531. doi: 10.3390/ijms26199531.

The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer's Disease and Schizophrenia

Russo AP, Pastorello Y, Dénes L, Brînzaniuc K, Krupinski J, Slevin M.

Int J Mol Sci. 2025 Jun 27;26(13):6237. doi: 10.3390/ijms26136237.

Unlocking the Future of Alzheimer's Disease: Innovations in Diagnosis and Therapy

Mehndiratta MM, Singla M, Dixit A.

J Assoc Physicians India. 2025 Aug;73(8):92-97. doi: 10.59556/japi.73.1075.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias